SCHEDULE 13G/A
Statement of Beneficial Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001274173-26-000102
Loading xslSCHEDULE_13G_X02/primary_doc.xml…
4D Molecular Therapeutics, Inc. Filed Acc 0001274173-26-000102
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…